Symbiotic-Lung-20: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Different Anticancer Agents in Advanced Cancers
A phase 1/2 trial of PF-08634404, PF-08046054 in non-small-cell lung cancer and small-cell lung cancer, run by Pfizer, now recruiting.
Overview
Symbiotic-Lung-20: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Different Anticancer Agents in Advanced Cancers is a phase 1/2 interventional study registered as NCT07227298 by Pfizer, with 162 participants planned, started 2026-01-30 and due to reach its primary completion in 2029-03-08. Interventions recorded: PF-08634404, Sigvotatug Vedotin, PF-08046054/SGN-PDL1V. Conditions listed: Advanced/Metastatic Non-Small Cell Lung Cancer, Carcinoma, Non-Small Cell Lung, Non-Small Cell Lung Cancer. No results are recorded here; the registry entry is the source.
Similar pages
not linked directly; found by shared links- TrialA Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)
Shares PF-08046054, Pfizer (incl. Seagen), Non-small-cell lung cancer.
- TrialSymbiotic-Lung-10: A Study to Learn About PF-08634404 Alone or in Combination in Early-stage or Locally Advanced NSCLC
Shares PF-08634404, Pfizer (incl. Seagen), Small-cell lung cancer, Non-small-cell lung cancer.
- TrialSymbiotic-Lung-14: A Study to Learn About the Study Medicine Called PF08634404 in Combination With Chemotherapy in Adult Participants With Transformed
Shares PF-08634404, Pfizer (incl. Seagen), Small-cell lung cancer.
- TrialSymbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
Shares PF-08634404, Pfizer (incl. Seagen), Non-small-cell lung cancer.
- TrialSymbiotic-Lung-04: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Extensive-Stage Small Cell Lung Cancer
Shares PF-08634404, Pfizer (incl. Seagen), Non-small-cell lung cancer.
- TrialSymbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
Shares PF-08634404, Pfizer (incl. Seagen).
- TrialThis is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lu
Shares Pfizer (incl. Seagen), Small-cell lung cancer, Non-small-cell lung cancer.
- TrialSSGJ-707 in Advanced Non-Small Cell Lung Cancer
Shares PF-08634404, Non-small-cell lung cancer.